Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - ANGIODYNAMICS INCex3215311510-k.htm
EX-21 - EXHIBIT 21 - ANGIODYNAMICS INCex2153115.htm
EX-3.1.2 - EXHIBIT 3.1.2 - ANGIODYNAMICS INCex31253115.htm
EX-10.1.5 - EXHIBIT 10.1.5 - ANGIODYNAMICS INCex101553115.htm
EX-10.4.3 - EXHIBIT 10.4.3 - ANGIODYNAMICS INCex104353115.htm
EX-23 - EXHIBIT 23 - ANGIODYNAMICS INCex23angio2015consent531151.htm
10-K - 10-K - ANGIODYNAMICS INCango-053115x10k.htm
EX-31.2 - EXHIBIT 31.2 - ANGIODYNAMICS INCex3125311510-k.htm
EX-31.1 - EXHIBIT 31.1 - ANGIODYNAMICS INCex3115311510-k.htm


Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,
UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Mark T. Frost, Executive Vice President, Chief Financial Officer of ANGIODYNAMICS, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

1.
the annual report on Form 10-K of the Company for the fiscal year ended May 31, 2015 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 10, 2015

/s/ Mark T. Frost
Mark T. Frost, Executive Vice President,
Chief Financial Officer